1[1]Furman B,Shoham VI,Bashiri A,et al.Clinical significance and outcome of preterm premature rupture of the membranes.Eur J Obstet Gynecol Reprod Biol,2000,92:209-216.
2[2]Vadillo-Ortega F,Hemandez A,Gonzalez-Avila G,et al.Increased matrix metalloproteinase activity and reduced tissue irrhibitor of metalloproteinases-1 levels in amniotic fluids from pregnancies complicated by premature rupture of membranes.Am J Obstet Gynecol,1996,174:1371-1376.
3[3]Joseph R,Patrick S,Suzanne P.Midtrimester amniotic fluid matrix metallo proteinase-8 (MMP-8) levels above the 90th percentile are a marker for subsequent prmature rupture of membranes.Am J Obstet Gynecol,2005,192:163-168.
4[4]Shaarawy M,E1-Minawi AM.Prolactin and calcitropic hormonesin preterm premature rupture of membranes.Int J Gynaecol Obstet,2004,84:200-207.
5[5]Locksmith GJ.Amniotic fluid concentrations of matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 during pregnancy and labor.Am J Obstet Gynecol,2001,184:159-164.
6[6]Fortunato SJ,Menon R.Screening of novel matrix metalloproteinases (MMPs) in human fetal membranes.J Assist Reprod Genet,2002,19:483-486.
7[7]Kugler A.Matrix metelloproteinases and their inhibitors.Anticancer Res,1999,19:1589-1592.
8[8]Maynon E,Romero R,Pacora P,et al.Evidence of in vivo differential bioavailability of the active form of matrix metalloproteinases 9 and 2 in parturition,spontaneous rupture of membranes,and intra amniotic infection.Am J Obstet Gynecol,2000,183:887-894.
9[9]Fortunato SJ,Menon R,Lombardi SJ.Stromelysins in placental membranes and amniotic fluid with premature rupture of membranes.Obstet Gynecol,1999,94:435-440.
10[10]Fortunato SJ,Lafleur B,Menon R.Collagenase-3 (MMP-13) in fetal membranes and intrauterine infection.Am J Reprod Immunol,2003,49:120-125.
